In this paper, a hybrid group acceptance sampling plan is introduced for a truncated life test if life times of the items follow size biased Lomax model. The minimum number of testers and acceptance number are obtained when the consumer's risk and the test termination time and group size are pre-specified. The operating characteristic values, minimum ratios of the true mean life to the specified mean life for the given producer's risk are also derived. The results are discussed through an example, a comparative study of proposed sampling plan with existing sampling plan are elaborated.
A new probability model size biased Lomax is considered for a life time random variable. The problem of acceptance sampling when the life test is truncated at a pre-assigned time is discussed with a known shape parameter. For various acceptance numbers, confidence levels and values of the ratio of the fixed experimental time to the specified mean life, the minimum sample size necessary to assure the specified mean life time is evaluated. The operating characteristic functions of the sampling plans are derived. Producer's risk is also discussed. A table for the ratio of true mean life to a specified mean life that ensure acceptance with a pre-assigned probability is provided. The results are given by an example.
A life time random variable which assumes a size biased Lomax model is considered as a measurable quality characteristic. In this paper,Decision lines are estimated using Analysis of Means (ANOM) technique for size biased Lomax distribution. Results are discussed through examples based on real data. Also, the results are compared with that of Shewart control charts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.